Basit öğe kaydını göster

dc.contributor.authorSarioguz, Eyluel
dc.contributor.authorKaraarslan, Cemre
dc.date.accessioned2023-09-15T13:15:09Z
dc.date.available2023-09-15T13:15:09Z
dc.date.issued2022
dc.identifier.issn2662-2041en_US
dc.identifier.urihttps://link.springer.com/article/10.1007/s42761-022-00128-3
dc.identifier.urihttp://hdl.handle.net/11727/10681
dc.description.abstractThe COVID-19 pandemic (and its aftermath) highlights a critical need to communicate health information effectively to the global public. Given that subtle differences in information framing can have meaningful effects on behavior, behavioral science research highlights a pressing question: Is it more effective to frame COVID-19 health messages in terms of potential losses (e.g., "If you do not practice these steps, you can endanger yourself and others") or potential gains (e.g., "If you practice these steps, you can protect yourself and others")? Collecting data in 48 languages from 15,929 participants in 84 countries, we experimentally tested the effects of message framing on COVID-19-related judgments, intentions, and feelings. Loss- (vs. gain-) framed messages increased self-reported anxiety among participants cross-nationally with little-to-no impact on policy attitudes, behavioral intentions, or information seeking relevant to pandemic risks. These results were consistent across 84 countries, three variations of the message framing wording, and 560 data processing and analytic choices. Thus, results provide an empirical answer to a global communication question and highlight the emotional toll of loss-framed messages. Critically, this work demonstrates the importance of considering unintended affective consequences when evaluating nudge-style interventions.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1007/s42761-022-00128-3en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMessage framingen_US
dc.subjectAnxietyen_US
dc.subjectNudgesen_US
dc.titleIn COVID-19 Health Messaging, Loss Framing Increases Anxiety with Little-to-No Concomitant Benefits: Experimental Evidence from 84 Countriesen_US
dc.typearticleen_US
dc.relation.journalAFFECTIVE SCIENCEen_US
dc.identifier.volume3en_US
dc.identifier.issue3en_US
dc.identifier.startpage577en_US
dc.identifier.endpage602en_US
dc.identifier.wos001045480200006en_US
dc.contributor.pubmedID36185503en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster